000 00978 a2200265 4500
005 20250515032637.0
264 0 _c20060808
008 200608s 0 0 eng d
022 _a1470-2045
024 7 _a10.1016/S1470-2045(06)70757-4
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGibson, Michael K
245 0 0 _aReassessment of the role of induction chemotherapy for head and neck cancer.
_h[electronic resource]
260 _bThe Lancet. Oncology
_cJul 2006
300 _a565-74 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aChemotherapy, Adjuvant
650 0 4 _aHead and Neck Neoplasms
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aNeoadjuvant Therapy
700 1 _aForastiere, Arlene A
773 0 _tThe Lancet. Oncology
_gvol. 7
_gno. 7
_gp. 565-74
856 4 0 _uhttps://doi.org/10.1016/S1470-2045(06)70757-4
_zAvailable from publisher's website
999 _c16406723
_d16406723